Hosted on MSN5h
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially ...
Medscape1d
Diet Changes Show Promise in Early Prostate Cancer
A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...
Australian women will soon be eligible for a menopause health check. Here’s what to expect
What is a menopause health assessment? And how will it improve the health care women receive during this stage in their lives ...
HealthDay on MSN3d
2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Procedures in Seniors
There was a notable decrease in common ophthalmic procedures among Medicare beneficiaries during the first year of the ...
EurekAlert!4d
Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
PMLiVE4d
Pfizer/Astellas share positive phase 3 results for Padcev in bladder cancer
The approvals were based on positive results from EV-302, in which Padcev plus Keytruda resulted in statistically significant ...